These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37625563)

  • 1. CircSOD2 polarizes macrophages towards the M1 phenotype to alleviate cisplatin resistance in gastric cancer cells by targeting the miR-1296/STAT1 axis.
    Qu B; Liu J; Peng Z; Xiao Z; Li S; Wu J; Li S; Luo J
    Gene; 2023 Dec; 887():147733. PubMed ID: 37625563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncGBP9/miR-34a axis drives macrophages toward a phenotype conducive for spinal cord injury repair via STAT1/STAT6 and SOCS3.
    Zhou J; Li Z; Wu T; Zhao Q; Zhao Q; Cao Y
    J Neuroinflammation; 2020 Apr; 17(1):134. PubMed ID: 32345320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages enhance cisplatin resistance in gastric cancer through the transfer of circTEX2.
    Qu B; Liu J; Peng Z; Xiao Z; Li S; Wu J; Li S; Luo J
    J Cell Mol Med; 2024 Mar; 28(5):e18070. PubMed ID: 38102848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis.
    Huangfu N; Zheng W; Xu Z; Wang S; Wang Y; Cheng J; Li Z; Cheng K; Zhang S; Chen X; Zhu J
    Int Immunopharmacol; 2020 Jun; 83():106432. PubMed ID: 32248017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-103 protects from recurrent spontaneous abortion via inhibiting STAT1 mediated M1 macrophage polarization.
    Zhu X; Liu H; Zhang Z; Wei R; Zhou X; Wang Z; Zhao L; Guo Q; Zhang Y; Chu C; Wang L; Li X
    Int J Biol Sci; 2020; 16(12):2248-2264. PubMed ID: 32549769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
    Guo Y; Yue P; Wang Y; Chen G; Li Y
    Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircSOD2 Contributes to Tumor Progression, Immune Evasion and Anti-PD-1 Resistance in Hepatocellular Carcinoma by Targeting miR-497-5p/ANXA11 Axis.
    Ye R; Lu X; Liu J; Duan Q; Xiao J; Duan X; Yue Z; Liu F
    Biochem Genet; 2023 Apr; 61(2):597-614. PubMed ID: 36008700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircRNA SOD2 motivates non-small cell lungs cancer advancement with EMT via acting as microRNA-2355-5p's competing endogenous RNA to mediate calmodulin regulated spectrin associated proteins-2.
    Lv C; Hu Y; Zhou X; Zhu Y; Wang J; Zhou F
    Bioengineered; 2022 Mar; 13(3):5756-5768. PubMed ID: 35188072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-19a-3p Suppresses M1 Macrophage Polarization by Inhibiting STAT1/IRF1 Pathway.
    Zhu X; Guo Q; Zou J; Wang B; Zhang Z; Wei R; Zhao L; Zhang Y; Chu C; Fu X; Li X
    Front Pharmacol; 2021; 12():614044. PubMed ID: 34017248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Associated Fibroblasts in Gastric Cancer Regulate Macrophage Polarization through RCN3 Pathway.
    Yang L; Zhou C; Zheng X; Zhang W
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):279. PubMed ID: 39206893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
    Sun G; Li Z; He Z; Wang W; Wang S; Zhang X; Cao J; Xu P; Wang H; Huang X; Xia Y; Lv J; Xuan Z; Jiang T; Fang L; Yang J; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2020 Nov; 39(1):246. PubMed ID: 33198772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway.
    Li G; Zhang Z; Chen Z; Liu B; Wu H
    Life Sci; 2021 Jul; 277():119419. PubMed ID: 33785336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
    Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
    Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
    Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
    [No Abstract]   [Full Text] [Related]  

  • 18. Long non-coding RNA FENDRR regulates IFNγ-induced M1 phenotype in macrophages.
    Munteanu MC; Huang C; Liang Y; Sathiaseelan R; Zeng X; Liu L
    Sci Rep; 2020 Aug; 10(1):13672. PubMed ID: 32792604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization.
    Xie C; Guo Y; Lou S
    Dig Dis Sci; 2020 Oct; 65(10):2863-2872. PubMed ID: 31894487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300/KAT6B axis.
    Cheng W; Luan P; Jin X
    Anticancer Drugs; 2023 Jan; 34(1):126-134. PubMed ID: 36206113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.